Home
Contact Us
Site Map
About Us
About Us
Management Team
Board of Directors
Locations
Contact Us
Pipeline
Pipeline
LX1033
Telotristat etiprate (LX1032)
LX2931
LX4211
LX7101
Research
Drug Discovery Research
Publications
Medicinal Chemistry
Partnering
Partnering
Collaborations
Careers
Careers
Opportunities
Our Culture
Benefits
Our Locations
News
Press Releases
Events & Webcasts
Investors
Investors
SEC Filings
Annual Reports
Corporate Governance
Clinical Trials
LX4211
Telotristat Etiprate (LX1032/LX1606)
LX1033
News
Dedicated to Innovation
Press Releases
Events & Webcasts
Press Releases
Filter
Title Filter
Display #
5
10
15
20
25
30
50
100
All
Lexicon to Present at the Bank of America Merrill Lynch Healthcare Conference
05/10/2013
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
05/09/2013
Lexicon Advances LX4211 in Type 1 Diabetes Phase 2 Trial
05/09/2013
Lexicon to Report First Quarter Financial Results on May 10, 2013
05/02/2013
Lexicon to Present at the Needham Healthcare Conference
04/24/2013
Lexicon to Present at the Cowen Healthcare Conference
02/28/2013
Lexicon Pharmaceuticals to Present at the Piper Jaffray Annual Healthcare Conference
11/16/2012
Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
11/05/2012
Lexicon Announces Pricing of Common Stock Offering
10/18/2012
Lexicon Announces Proposed Common Stock Offering
10/17/2012
Page 1 of 44
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»